NCCN Updates Clinical Practice Guideline for Multiple Myeloma

HealthClot Feature Image

NCCN Updates Clinical Practice Guideline for Multiple Myeloma

On March 15, 2021, the National Comprehensive Cancer Network (NCCN) released an update to its clinical practice guideline for multiple myeloma.

In the section for therapy for previously treated multiple myeloma, under other regimens, melphalan flufenamide/dexamethasone was added as a category 2A recommendation.—Janelle Bradley

Published at Tue, 16 Mar 2021 02:40:18 +0000

Leave a Reply

Your email address will not be published.